bioRxiv ScienceSearch

bioRxiv · 10.1101/2020.03.09.983296

Localization of regions of a Bordetella pertussis autotransporter, Vag8, interacting with C1 inhibitor

Abstract

Bordetella pertussis is the causative agent of pertussis (whooping cough), a contagious respiratory disease that has recently seen a resurgence despite high vaccination coverage, necessitating improvement of current pertussis vaccines. An autotransporter of B. pertussis, virulence-associated gene 8 (Vag8), has been proposed as an additional component to improve pertussis vaccines. Vag8 is known to play a role in evasion of the complement system and activation of the contact system by inactivating the complement regulating factor, C1 inhibitor (C1 Inh), which inhibits serine proteases, such as plasma kallikrein (PK). However, the nature of the molecular interaction between Vag8 and C1 Inh remains to be determined. In the present study, we attempted to determine the minimum region of Vag8 that interacts with C1 Inh by examining the differently-truncated Vag8 derivatives for the ability to bind and inactivate C1 Inh. The region of Vag8 from amino-acid residues 102 to 548 was found to bind C1 Inh and cancel its inhibitory action on the protease activity of PK at the same level as a Vag8 fragment from amino-acid residues 52 to 648 covering the passenger domain, which carries its extracellular function. In contrast, the truncated Vag8 containing amino-acid residues 102 - 479 or 202 - 648 barely interacted with C1 Inh. These results indicated that the two separate regions of amino-acid residues 102 - 202 and 479 - 548 are likely required for the interaction with C1 Inh. ImportancePertussis is currently reemerging worldwide, and is still one of the greatest disease burdens in infants. B. pertussis produces a number of virulence factors, including toxins, adhesins, and autotransporters. One of the autotransporters, Vag8, which binds and inactivates the complement regulator C1 Inh, is considered to contribute to the establishment of B. pertussis infection. However, the nature of the interaction between Vag8 and C1 Inh remains to be explored. In this study, we narrowed down the region of Vag8 that interacts with C1 Inh and demonstrated that at least two separate regions of Vag8 are necessary for the interaction with C1 Inh. Our results provide insight into the structure-function relationship of the Vag8 molecule and information to determine its potential role in the pathogenesis of B. pertussis.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Onoda, N., Hiramatsu, Y., Teruya, S., Suzuki, K., Horiguchi, Y.. 2020-03-09. Localization of regions of a Bordetella pertussis autotransporter, Vag8, interacting with C1 inhibitor. https://doi.org/10.1101/2020.03.09.983296

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology